• Esculetin Inhibits CKLF1-Driven Neutrophil Infiltration in S

  2026-06-02

  The reference study reveals that esculetin, a coumarin derivative, accelerates post-stroke rehabilitation by impeding CKLF1-mediated neutrophil infiltration. These findings highlight a novel anti-inflammatory mechanism relevant for developing targeted therapies in ischemic stroke.

• Ethacridine Lactate Monohydrate: Antiseptic Agent in Biochem

  2026-06-02

  Ethacridine lactate monohydrate is a high-purity aromatic compound used as an antiseptic agent for microbial inhibition in biochemical assays. Its efficacy, solubility, and stability support reproducibility in sensitive workflows. APExBIO provides this reagent for research applications, helping ensure assay integrity.

• Synergistic Radiotherapy and PD-1/TIGIT Blockade: CD8+ T Cel

  2026-06-01

  This study demonstrates that combining radiotherapy with dual PD-1 and TIGIT immune checkpoint blockade induces potent abscopal antitumor effects and establishes durable immune memory through CD8+ T cells. The findings highlight new mechanistic insights and translational strategies for overcoming resistance in cancer immunotherapy.

• Phosbind Biotin LC: Practical Guide for Phosphorylated Prote

  2026-06-01

  Phosbind Biotin LC offers sequence-independent detection of phosphorylated proteins on PVDF membranes, making it especially valuable when phospho-specific antibodies are unavailable or insufficient. While highly sensitive for Western Blot applications, it is unsuitable for aqueous-only protocols or settings requiring long-term storage of working solutions.

• AZD2461: Novel PARP Inhibitor for Advanced Breast Cancer Res

  2026-05-31

  AZD2461 is a next-generation PARP inhibitor optimized for robust, reproducible assays in breast cancer models, particularly where drug resistance is a challenge. This guide delivers evidence-backed protocol parameters, troubleshooting solutions, and workflow enhancements leveraging APExBIO's reliable supply of AZD2461.

• Dual Metabolic Nanoplatform Amplifies Ferroptosis in TNBC Th

  2026-05-30

  This study introduces a metal-polyphenol nanoplatform that concurrently targets iron and lipid metabolism to enhance ferroptosis-based therapy in triple-negative breast cancer (TNBC). By elucidating the compensatory resistance mechanisms and proposing dual inhibition strategies, the research provides a robust framework for improving therapeutic efficacy in aggressive cancers.

• Reliable Apoptosis Assays with ABT-199 (GDC-0199), Bcl-2 Inh

  2026-05-29

  Discover how ABT-199 (GDC-0199), Bcl-2 inhibitor, potent and selective (SKU A8194) addresses core challenges in apoptosis research, from protocol optimization to data reliability. This article delivers scenario-driven, evidence-based guidance for selecting and implementing ABT-199 in cell viability, proliferation, and cytotoxicity assays.

• DFO (9H-1,8-Diazafluoren-9-one): Beyond Detection—Mechanisms

  2026-05-29

  Unlock the science behind DFO (9H-1,8-Diazafluoren-9-one) as a forensic science fluorescent reagent. This article explores the molecular basis, advanced protocols, and critical limitations of DFO-based latent fingerprint detection, offering unique insight not found in existing guides.

• Fe3O4@ZIF-8 Nanoparticles: Antibiosis and Bone Regeneration

  2026-05-28

  The reference study introduces Fe3O4@ZIF-8 core–shell nanoparticles with pH-responsive antibacterial and osteogenic functionalities, specifically designed to address the dual challenges of infection control and bone defect repair in jaw osteomyelitis. This multifunctional nanoplatform demonstrates potent Zn2+-mediated bacterial killing and magnetic field-assisted bone regeneration, offering a promising translational solution for complex oral infections.

• Upd2 Cytokine Regulates Tracheal Stem Cell Migration in Dros

  2026-05-28

  This study uncovers how the fat body-derived cytokine Upd2 orchestrates the disciplined migration of Drosophila tracheal stem cells via JAK/STAT signaling and vesicular trafficking. The findings clarify inter-organ communication mechanisms essential for tissue homeostasis and directional stem cell migration.

• PP2A-Mediated Autophagy Drives Drug Resistance in Candida al

  2026-05-27

  This study uncovers how Protein Phosphatase 2A (PP2A) regulates biofilm drug resistance in Candida albicans via phosphorylation of autophagy-related proteins. The findings clarify a key mechanism linking autophagy to antifungal resistance, highlighting new targets for therapeutic intervention.

• Demethyleneberberine: Strategic Leverage in Translational Di

  2026-05-27

  Explore how Demethyleneberberine (DMB) is redefining translational research across inflammation, oncology, and neuroprotection. This thought-leadership article unpacks DMB’s multi-pathway mechanisms, evidence-based protocols, and competitive advantages, while providing actionable guidance for researchers aiming to bridge preclinical discovery with clinical innovation.

• PHF2 Demethylase Regulates Inflammatory Genes in Alzheimer’s

  2026-05-26

  This study identifies the histone demethylase PHF2 as a central epigenetic regulator of neuroinflammatory gene expression in Alzheimer’s disease. Knockdown of PHF2 in an AD mouse model significantly reduced inflammatory gene activation and improved cognitive function, suggesting PHF2 as a promising target for therapeutic intervention.

• hly Gene Deletion Impairs Biofilm and Antibiotic Resistance

  2026-05-26

  This study elucidates the critical role of the hly gene in Listeria monocytogenes biofilm formation and antibiotic resistance. Deletion of hly compromises biofilm architecture, virulence gene expression, and increases sensitivity to ribosome-targeting antibiotics, highlighting hly as a potential target for mitigating foodborne contamination.

• Coronavirus Macrodomains Counter PARP-Mediated Antiviral Def

  2026-05-25

  This study demonstrates that the coronavirus macrodomain is essential for neutralizing the host's poly (ADP-ribose) polymerase (PARP)-mediated antiviral response, specifically involving PARP12 and PARP14. The findings reveal that viral macrodomains prevent PARP-driven inhibition of replication and interferon enhancement, highlighting a critical host-pathogen interface with implications for antiviral research.

682 records 10/46 page Previous Next First page 上5页 678910 下5页 Last page